Literature DB >> 19064202

Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques.

Joseph C J Bot1, Frederik Barkhof.   

Abstract

Multiple sclerosis is a diffuse disease of the central nervous system, and MRI of the spinal cord is highly recommended in the clinical evaluation of patients suspected of having multiple sclerosis. Within the new diagnostic criteria, spinal cord MRI increases sensitivity and possibly specificity for MS, but further work is needed to investigate other criteria that may give greater weight to the presence of cord lesions in patients with clinically isolated syndromes or suspected relapsing-remitting multiple sclerosis. Techniques should be further studied and validated in studies comparing these techniques with clinical status and histopathology, however.

Entities:  

Mesh:

Year:  2009        PMID: 19064202     DOI: 10.1016/j.nic.2008.09.005

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  25 in total

Review 1.  MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Authors:  Frederik Barkhof; Jack H Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola de Stefano; Chris H Polman; John Petkau; Ernst W Radue; Maria P Sormani; David K Li; Paul O'Connor; Xavier Montalban; David H Miller; Massimo Filippi
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.

Authors:  Leonard H Verhey; Helen M Branson; Monica Makhija; Manohar Shroff; Brenda Banwell
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

Review 3.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

4.  Multiparametric MRI reveals dynamic changes in molecular signatures of injured spinal cord in monkeys.

Authors:  Feng Wang; Hui-Xin Qi; Zhongliang Zu; Arabinda Mishra; Chaohui Tang; John C Gore; Li Min Chen
Journal:  Magn Reson Med       Date:  2014-10-21       Impact factor: 4.668

Review 5.  Magnetic resonance imaging in immune-mediated myelopathies.

Authors:  M J Wendebourg; S Nagy; T Derfuss; K Parmar; R Schlaeger
Journal:  J Neurol       Date:  2019-01-29       Impact factor: 4.849

6.  Longitudinal assessment of spinal cord injuries in nonhuman primates with quantitative magnetization transfer.

Authors:  Feng Wang; Ke Li; Arabinda Mishra; Daniel Gochberg; Li Min Chen; John C Gore
Journal:  Magn Reson Med       Date:  2015-05-08       Impact factor: 4.668

Review 7.  Progressive multiple sclerosis and gray matter pathology: an MRI perspective.

Authors:  Matilde Inglese; Niels Oesingmann; Patrizia Casaccia; Lazar Fleysher
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

Review 8.  Clinical Course of Multiple Sclerosis.

Authors:  Sylvia Klineova; Fred D Lublin
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

9.  Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.

Authors:  Kathleen M Zackowski; Seth A Smith; Daniel S Reich; Eliza Gordon-Lipkin; BettyAnn A Chodkowski; Divya R Sambandan; Michael Shteyman; Amy J Bastian; Peter C van Zijl; Peter A Calabresi
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

10.  Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.

Authors:  Arzu Ozturk; Nafi Aygun; Seth A Smith; Brian Caffo; Peter A Calabresi; Daniel S Reich
Journal:  Neuroradiology       Date:  2012-12-04       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.